Activation of CRH receptor type 1 expressed on glutamatergic neurons increases excitability of CA1 pyramidal neurons by the modulation of voltage-gated ion channels by Stephan Kratzer et al.
ORIGINAL RESEARCH ARTICLE
published: 19 July 2013
doi: 10.3389/fncel.2013.00091
Activation of CRH receptor type 1 expressed on
glutamatergic neurons increases excitability of CA1
pyramidal neurons by the modulation of voltage-gated
ion channels
Stephan Kratzer1, Corinna Mattusch1, Michael W. Metzger2, Nina Dedic2,3, Michael Noll-Hussong4,
Karl W. Kafitz5, Matthias Eder6, Jan M. Deussing2,3, Florian Holsboer7, Eberhard Kochs1 and
Gerhard Rammes1*
1 Department of Anesthesiology, Klinikum Rechts der Isar der Technischen Universität München, Munich, Germany
2 RG Molecular Neurogenetics, Max Planck Institute of Psychiatry, Munich, Germany
3 Clinical Cooperation Group Molecular Neurogenetics, Institute of Developmental Genetics, Helmholtz Center Munich, Neuherberg, Germany
4 Department of Psychosomatic Medicine and Psychotherapy, University of Ulm, Ulm, Germany
5 Faculty of Mathematics and Natural Sciences, Institute of Neurobiology, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
6 RG Neuronal Network Dynamics, Max Planck Institute of Psychiatry, Munich, Germany
7 Max Planck Institute of Psychiatry, Munich, Germany
Edited by:
Andreas Frick, INSERM, France
Reviewed by:
Alon Korngreen, Bar-Ilan University,
Israel
Stuart Hughes, Cardiff University,
UK
*Correspondence:
Gerhard Rammes, Department of
Anesthesiology, Klinikum Rechts der
Isar der Technischen Universität
München, Ismaninger Straße 22,
81675 Munich, Germany
e-mail: rammes@mpipsykl.mpg.de
Corticotropin-releasing hormone (CRH) plays an important role in a substantial number of
patients with stress-related mental disorders, such as anxiety disorders and depression.
CRH has been shown to increase neuronal excitability in the hippocampus, but the
underlying mechanisms are poorly understood. The effects of CRH on neuronal excitability
were investigated in acute hippocampal brain slices. Population spikes (PS) and field
excitatory postsynaptic potentials (fEPSP) were evoked by stimulating Schaffer-collaterals
and recorded simultaneously from the somatic and dendritic region of CA1 pyramidal
neurons. CRH was found to increase PS amplitudes (mean ± Standard error of the
mean; 231.8 ± 31.2% of control; n = 10) while neither affecting fEPSPs (104.3 ± 4.2%;
n = 10) nor long-term potentiation (LTP). However, when Schaffer-collaterals were excited
via action potentials (APs) generated by stimulation of CA3 pyramidal neurons, CRH
increased fEPSP amplitudes (119.8 ± 3.6%; n = 8) and the magnitude of LTP in the
CA1 region. Experiments in slices from transgenic mice revealed that the effect on PS
amplitude is mediated exclusively by CRH receptor 1 (CRHR1) expressed on glutamatergic
neurons. The effects of CRH on PS were dependent on phosphatase-2B, L- and T-type
calcium channels and voltage-gated potassium channels but independent on intracellular
Ca2+-elevation. In patch-clamp experiments, CRH increased the frequency and decay
times of APs and decreased currents through A-type and delayed-rectifier potassium
channels. These results suggest that CRH does not affect synaptic transmission per se,
but modulates voltage-gated ion currents important for the generation of APs and hence
elevates by this route overall neuronal activity.
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INTRODUCTION
The neuropeptide corticotropin-releasing hormone (CRH) is the
main regulator for the hypothalamic-pituitary-adrenal (HPA)
axis and plays a central role in the mammalian adaptive response
to stress (Bonfiglio et al., 2011). Besides inducing synthesis and
release of adrenocorticotropic hormone (ACTH) secretion from
the anterior pituitary, CRH exerts a wide spectrum of behavioral
and autonomic effects in the central nervous system (Hillhouse
and Grammatopoulos, 2006).
Abbreviations: CRH, corticotropin-releasing hormone; CRHR, corticotropin-
releasing hormone receptor; fEPSPs, field excitatory postsynaptic potentials; HFS,
high frequency stimulation; LTP, long-term potentiation; PS, population spike; SC,
schaffer-collaterals; VGCC, voltage gated calcium channels.
Increased expression and release of CRH not only results in
activation of the neuroendocrine HPA-axis, but via projections
from the hypothalamus and on-site production at other brain
locations also in behavioral changes important to adapt to stress.
Once stressors persist the continuous hyperactivity of CRH neu-
rons can lead to anxiety- and depression-like behavior in animals.
Increased concentrations of CRH were found in the cerebrospinal
fluid (CSF) of a subset of patients with depression (Nemeroff
et al., 1984; Holsboer, 2000) and also a number of endocrine
function tests (Holsboer, 2000) were in agreement with eleva-
tions of central CRH in many severely depressed patients. Due
to these and other findings CRH and its two receptors (CRHR1
and CRHR2) became the focus of studies of causality of mood
disorders and the search for pharmacological targets.
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The hippocampal formation (HF) plays a key role in memory
storage and learning, however, in recent years it has also received
significant attention in mood disorder research. The release of
endogenous hippocampal CRH can be induced by physiologi-
cal stress (Chen et al., 2004). Direct injection of CRH into the
dentate gyrus enhanced memory retention in rats (Lee et al.,
1993), whereas injection into the dorsal hippocampus improved
context- and tone-dependent fear conditioning (Radulovic et al.,
1999). In patients with major depressive disorder, imaging studies
showed structural and functional alterations in the HF (Campbell
and MacQueen, 2004). CRH-immunoreactive cells can be found
in the hippocampus of rats at P1 and the number of these
neurons increases until P18 (Chen et al., 2001). Most of the
CRH-releasing cells are GABAergic neurons that build synapses
on the somata of pyramidal neurons. This anatomical loca-
tion provides them a significant influence on pyramidal cell
activity and information flow (Korosi and Baram, 2008) since
CRHR1 is discussed to be expressed on pyramidal neurons
(Aguilera et al., 2004).
Within the mouse hippocampus, CRH has been shown to be
synthesized in GABAergic neurons and mRNA encoding CRHR1
was found in the hippocampal subregions CA1 and CA3 in mice
(Van Pett et al., 2000).
The effect of CRH on neuronal activity within the HF is still
not entirely understood. Previous studies showed a long last-
ing enhancement of synaptic efficacy in the hippocampus (Wang
et al., 1998), an enhancement of CA1 population spikes (PS)
and an increase in firing frequency of rat hippocampal neurons
(Aldenhoff et al., 1983; Blank et al., 2002; Sillaber et al., 2002).
Another study using the voltage-sensitive dye imaging technique
in acute slices described a CRHR1 dependent increase in neuronal
activity propagation through the HF (von Wolff et al., 2011). The
exact mechanism how CRH mediates these versatile actions is
still unclear. In this explorative study we investigated the influ-
ence of CRH on neuronal excitability of CA1 principal neurons
in rodents to further elucidate the underlying mechanisms of the
CRH action.
MATERIALS AND METHODS
ANIMALS
The experimental protocols were approved by the Ethical
Committee on Animal Care and Use of the Government of
Bavaria (Munich, Germany).
Mice lacking CRHR1 on glutamatergic and GABAergic neu-
rons, respectively, have been described previously (Refojo et al.,
2011). Briefly: Homozygous floxed CRHR1mice (CRHR1flox/flox)
were bred to Nex-Cre mice resulting in the F2 generation in
CRHR1flox/flox Nex-Cre mice (CRHR1Glu-CKO) lacking CRHR1
on glutamatergic neurons. Homozygous floxed CRHR1 mice
(CRHR1flox/flox) to Dlx5/6-Cre mice resulting in the F2 gen-
eration in CRHR1flox/flox Dlx5/6-Cre mice (CRHR1GABA-CKO)
lacking CRHR1 on GABAergic neurons. As controls respective
homozygous floxed littermates lacking Cre recombinase were
used (CRHR1Ctrl). Both mouse lines are on a mixed 129S2/Sv ×
C57BL/6J genetic background.
Mice harboring a conditional CaV1.2 allele (CaV1.2loxP) have
been described previously (Seisenberger et al., 2000). Conditional
knockout mice devoid of CaV1.2 in the entire central nervous
system were generated by breeding CaV1.2loxP/loxP to CaV1.2±
Nestin-Cre mice, resulting in CNS specific CaV1.2 knockout
mice (CaV1.2CNS-CKO; CaV1.2−/loxP Nestin-Cre) and respective
control mice (CaV1.2ctrl; CaV1.2+/loxP Nestin-Cre).
ELECTROPHYSIOLOGY
Male CD1 or transgenic mice were anesthetized with isoflu-
rane and after decapitation, brains were quickly transferred into
ice-cold carbogenated (95% O2/5% CO2) artificial cerebrospinal
fluid (aCSF), and sagittal hippocampal slices (350μm) were cut
using a vibratome (HM 650V, Microm International, Walldorf,
Germany). Afterwards, slices were allowed to recover for at least
1 h at 34◦C before being transferred to the recording chamber
where they were continuously superfused with aCSF at a rate
of 5ml/min. The aCSF contained (in mM): NaCl, 124; KCl, 3;
NaHCO3, 26; CaCl2, 2; MgSO4, 1; D-glucose, 25; NaH2PO4, 1.25,
and was bubbled with carbogen (95% O2/5% CO2, final pH 7.3).
CRH (rat/human; 125 nM final concentration, Sigma-Aldrich,
Germany) was bath applied. All experiments were performed at
room temperature (20–24◦C).
Extracellular recordings in slices from mice (p 42–56) were
performed using glass microelectrodes (2–3M) filled with
aCSF. For recording of field excitatory postsynaptic potentials
(fEPSPs) the electrode was placed in the CA1 stratum radiatum
and for measurement of PS electrodes were placed in the CA1
stratum pyramidale. PS and fEPSPs were evoked by electrical
stimulation of the Schaffer-collaterals (SC) with a bipolar tung-
sten electrode (SC-stim-fEPSPs; simulations intensities between
1 and 20 Volts for 50μs). In the majority of the experiments, fEP-
SPs and PS were recorded simultaneously. Stimulation intensities
were set to record SC-stim-fEPSPs without PS in CA1 stratum
radiatum for one electrode and to record PS in CA1 stratum
pyramidale for the other electrode. In a subset of experiments,
the stimulation electrode was positioned in the CA3 pyramidal
layer to stimulate the somata of CA3 pyramidal neurons and fEP-
SPs were recorded in CA1 stratum radiatum (CA3-stim-fEPSPs).
This ensures the inclusion of an AP generation site within the
recorded circuit and the transmitter release depends on somatic
action potential (AP) initiation and axonal signal propagation.
The influence of CRH on hippocampal long-term potentiation
(LTP) of SC-stim-fEPSPs and CA3-stim-fEPSPs was investigated
in another subset of experiments. For that purpose, a high-
frequency stimulation (HFS; 100Hz/1 s) train was applied on
either the SC or the CA3 stratum pyramidale.
Whole cell patch-clamp recordings in slices from mice
(p 28–42) were obtained from CA1 pyramidal neurons using
infrared videomicroscopy (Dodt et al., 1999). The recording
pipettes (resistance between 4.5 and 5M) were filled with (in
mM) K-D-gluconate, 130; KCl, 5; EGTA, 0.5; Mg-ATP, 2; HEPES,
10; D-glucose, 5. Currents and potentials were recorded by a dis-
continuous voltage clamp amplifier (SEC 10, NPI electronics,
Tamm, Germany) in the voltage-clampmode (switching frequen-
cies 40–43 kHz, 25% duty cycle) and bridge mode, respectively.
Voltage-clamp experiments were performed at a holding
potential of −50mV. For the measurement of potassium cur-
rents, cells were stepwise depolarized from the holding potential
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to +40mV in 10mV steps. In adult neurons potassium currents
are composed of a rapidly inactivating A current (IA), a delayed
rectifier current (IK) and a slowly inactivating K+ current (IS).
Delivery of a short hyperpolarizing step to −100mV preceding
the depolarization removes a substantial portion of the inacti-
vation from the fast IA without de-inactivating IS (Figure 6B).
Depolarization from a more positive potential (−50mV) acti-
vates only IK as IA is inactivated (Figure 6A). By graphical sub-
traction of currents resulting from voltage steps with and without
the preceding hyperpolarizing step, IA currents can be analyzed
(Figure 6C). Sodium currents were measured by depolarization
of CA1 neurons from a holding potential of −70 to −20mV
in 2mV steps. For sodium current recordings, the pipettes were
filled with (in mM) CsCl, 75; NaF, 75; MgCl2, 2; HEPES, 10;
EGTA, 2.5; Na2ATP, 3 and slices were perfused with aCSF contain-
ing (in MM) NaCl, 80; Tetramethylammonium chloride, 45; KCl,
2.5; NaH2PO4, 1.25; D-glucose, 25; NaHCO3, 25; MgCl2, 1; CaCl,
2. For leak subtraction, the P/4 subtraction protocol was used.
For measuring the effect of CRH on L-type and T-type cal-
cium channels in CA1 pyramidal cells, we substituted calcium in
the extracellular solution with barium and thus recorded barium
currents through calcium channels. The extracellular solution
contained (in mM): NaCl 125, KCl 2.5, NaHCO3 25, CaCl2 2,
BaCl2 1, D-glucose 25, NaH2PO4 1.25. Pipettes were filled
with an intracellular solution containing (in mM): Cs-methane
sulphonate 110, EGTA 0.5, MgCl2 2, HEPES 10, D-glucose 5,
Na2-phosphocreatine 14, Mg-ATP 5 and Na-GTP 0.3. L-type and
T-type calcium channel currents were recorded by adding specific
antagonists to the aCSF: ω-Conotoxin GVIA (1μM) for N-type
channels and ω-Agatoxin IVA (100 nM) for P/Q-type channels.
Cells were held at−90mV and a step to −40mV was used to acti-
vate and inactivate the T current. After repolarization to −50mV,
a step to 0mV was used to activate the L-current.
CALCIUM IMAGING
In a subset of experiments, Ca2+ influx into CA1 pyramidal
neurons upon electrical stimulation of the SC was measured
by fluorometric calcium imaging. Therefore slices were loaded
with the membrane soluble acetoxymethyl (AM) ester of ore-
gon green (Invitrogen, Darmstadt, Germany) dissolved in DMSO
+ 20% Pluronic F-127 at a stock concentration of 5mM. For
neuron staining, the stock solution was diluted 1:10 with HEPES-
aCSF (in mM: NaCl 125, KCl 3, HEPES 25, MgSO4 2, CaCl2 2,
NaH2PO4 1.25) which resulted in a final dye concentration of
500μM oregon green-AM. The dye was applied to the somata of
CA1 neurons by ejecting it from a micropipette (open tip resis-
tance 0.5M) with a mild pressure pulse. Cells were allowed to
uptake the dye for 1 h before the beginning of recordings. Imaging
was performed with a 60X-water immersion objective (numerical
aperture 0.9; Olympus, Hamburg, Germany), and a filter block
containing a 530/25 filter (band pass) and 510 dichroic mirror. A
monochromator (Polychrome V; T.I.L.L. Photonics; Martinsried;
Germany) was used for excitation with a wavelength of 494 nm
and emission was collected at a maximum of 523 nm. For mea-
surements of calcium-dependent changes in fluorescence, images
were sampled during stimulation to the SC for 1.5 s at 20Hz
and recorded with a high speed CCD camera (Retiga-2000RV;
Qimaging; Surrey; Canada). Extracellular PS recordings were per-
formed in parallel to the imaging measurements for verifying
the CRH effect. Data acquisition and offline data analysis were
performed with TillVision software (T.I.L.L. Photonics). Baseline
fluorescence before electrical stimulation (F0) and relative fluo-
rescence changes (F/F0) in defined regions of interest (ROIs)
positioned to the cell somata in CA1 were measured through-
out the image sequence. Changes in intracellular calcium levels
are expressed as F/F0. The time integral (area under the curve;
AUC) was used to assess changes in total calcium.
ANALYSIS OF DATA
Amplified currents, fEPSPs, and PSs were filtered (3 kHz), dig-
itized (15 kHz) using a laboratory interface board (ITC-16,
Instrutech Corp., USA) and stored to disk on a Power Macintosh
G3 computer with the acquisition program Pulse, version 8.5
(Heka Electronic GmbH, Lambrecht, Germany). To measure PS
amplitude the voltage difference between the sharp negative onset
and the negative peak (a) and the one between the negative
peak and the succeeding positive peak (b) was displayed, and
the amplitude of the PS was calculated as (a + b)/2. All values
were statistically analyzed using Student’s paired t-test or Mann-
Whitney-U test with a level of p < 0.05 required for significance.
Averaged values are shown as mean ± SEM.
DRUGS
Drugs were applied via the superfusion system. Compounds
used: All salts for the pipette solution and aCSF, K252a, H-89
dihydrochloride hydrate, H-7 dihydrochloride, Cyclosporine A
and nifedipine were purchased from Sigma Aldrich (Munich,
Germany). Oregon Green was obtained from Life Technologies
GmbH (Darmstadt, Germany) and CRH (human/rat) from
Bachem (Weil am Rhein, Germany).
RESULTS
To test whether the effect of CRH on PS amplitude also results
in increased fEPSP amplitudes one recording electrode was posi-
tioned in the stratum radiatum and one electrode in the stratum
pyramidale for parallel recording of fEPSPs (SC-stim-fEPSPs) and
PS, evoked by orthodromic and antidromic electrical stimulation
of the SC with two stimulation electrodes. In CA1 region, CRH
(125 nM) strongly enhanced PS amplitude to 231.8 ± 31.2%
(n = 10; p < 0.05; Figure 1) with no effect on fEPSP amplitude
104.3 ± 4.2% (n = 10; p > 0.05; Figure 1).
To investigate whether the effect of CRH is dependent
on CRHR1 expression on glutamatergic or GABAergic neu-
rons, slices from conditional knock-out animals were used.
In CRHR1Ctrl mice CRH 125 nM increased the PS ampli-
tude to 154.7 ± 10.2% of control (n = 7; p < 0.05; Figure 2).
In CRHR1Glu-CKO mice the effect of CRH was abolished
(98.2 ± 2.0% of control; n = 7; p > 0.05; Figure 2) whereas in
CRHR1GABA-CKO mice CRH increased PS amplitudes to 144.5 ±
9.5% of control (n = 7; p > 0.05 vs. CRHR1flox/flox; Figure 2).
The CRH-mediated increase in PS amplitudes in CA1 might
be mediated by increased somatic excitability by e.g., lowered
threshold for AP (AP) generation. CRH increased CA3-stim-
fEPSP amplitudes to 119.8 ± 3.6% of control (n = 8; p < 0.05;
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FIGURE 1 | When Schaffer-collaterals are electrically stimulated CRH
increases the population spike (PS) amplitude without affecting field
excitatory postsynaptic potentials (fEPSPs). Acute sagittal hippocampal
brain slices were obtained from male CD-1 mice (P30–P50). Dual recording
was performed by positioning one electrode in the stratum radiatum of the
CA1 region for monitoring fEPSPs (SC-stim-fEPSPs; white symbols) and the
second electrode was positioned in the pyramidal layer for monitoring PS
(black symbols). After 10min of reaching a stable baseline, CRH (125 nM) was
applied to the perfusion medium. CRH increases PS amplitudes to
231.8 ± 31.2% of baseline level (n = 10; p < 0.05) without affecting fEPSP
slope (104.3 ± 4.2% of control; n = 10; p > 0.05). In a subset of experiments
the stimulation electrode was positioned in the CA3 pyramidal layer and
fEPSPs were recorded from the CA1 stratum radiatum (CA3-stim-fEPSPs;
gray symbols). This stimulation technique allows the inclusion of an action
potential generation site and, consequently, transmitter release at CA3-CA1
synapses is dependent on somatic action potential initiation and axonal signal
propagation. Under these conditions, CRH (125 nM) significantly increased
CA3-stim-fEPSP amplitudes to 119.8 ± 3.6% of control (n = 8; p < 0.05).
Each data point represents the mean ± SEM of 4 consecutive fEPSP/PS
amplitude measurements normalized to the last 5min before CRH
application. Insets show representative recording traces; § stimulation
artifact. Black bar indicates presence of CRH.
Figure 1). HFS applied to the SC induced LTP of SC-stim-
fEPSPs to 173.3 ± 19.8% of control (n = 5; Figure 3A) which
was not affected in the presence of CRH (171.3 ± 8.2%; n = 5;
p > 0.05 for control vs. CRH Figure 3A). When the same HFS
was delivered to the somatic region of CA3 pyramidal neurons,
the magnitude of CA3-stim-LTP was significantly increased after
the application of CRH (180.6 ± 8.1% vs. 154.8 ± 5.0%; n = 6;
p < 0.05; Figure 3B).
To elucidate the neuronal mechanisms how CRH enhances
the PS amplitude slices were incubated with either K252a
(500 nM), H7 (100μM), H89 (10μM), Nifedipine (20μM),
and Ni+ (50μM), Cyclosporine A (cycA; 50μM) or 4-AP
(100μM) to block protein kinase A (PKA), protein kinase C
(PKC), Ca2+/calmodulin-dependent protein kinase (CaMKII),
T- or L-type Ca2+-channels, protein phosphatase 2B (PP-2B/
Calcineurin) and voltage-gated K+-channels (KV). The CRH-
induced enhancement of PS amplitudes could be prevented
by antagonising T- and L-type Ca2+-channels (96.2 ± 7.3%;
n = 6; p > 0.05; Figure 3C), KV (113.6 ± 6.2%; n = 6; p >
0.05; Figure 3C), and PP2B (98.4 ± 5.1%; n = 6; p > 0.05;
Figure 3C). These results suggest a PP-2B and L-type calcium
channel dependent mechanism. Application of the potassium
channel antagonist 4-AP lead to increased PS amplitude and
evoked epileptiform activity (repeated PS upon electrical stim-
ulation). Previous to CRH application, stimulation intensity was
reduced to basal levels eliciting only one single PS. Interestingly,
the blockade of PKA and PKC activity with H7 induced a dra-
matic increase in PS amplitude per se to 424.6 ± 10.2% of control
(n = 5; p < 0.05; data not shown). Previous to CRH application,
PS amplitudes were reset to control.
Our experiments suggest an involvement of T- and L-type
calcium channels in the CRH-mediated effect on PS amplitude.
Thus, we monitored somatic intracellular Ca2+ influx in the pres-
ence of CRH. Application of CRH for 20min did not change
the cytosolic calcium level and hence F/F (data not shown).
However, when Ca2+ influx has been monitored during electri-
cal stimulation of the SC, in the presence of CRH (125 nM) the
AUC of the calcium signal was significantly increased to 231.7 ±
13.8% of control (n = 4; p < 0.05; Figure 4A). To further inves-
tigate the involvement of T- and L-type calcium channels in the
CRH-mediated increase in PS amplitude, experiments in CaV1.2
knockout animals were performed. In CaV1.2 knockout animals,
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FIGURE 2 | The CRH-mediated effect depends on CRH receptor type 1
(CRHR1) expression on glutamatergic neurons. Slices were prepared from
conditional knock-out mice lacking CRHR1 either on glutamatergic neurons
(CRHR1Glu-CKO) or on GABAergic neurons (CRHR1GABA-CKO). CRHR1flox/flox
mice littermates served as control.CRH increases PS amplitude in slices from
CRHR1ctrl to 154.7 ± 10.2% (n = 7; p < 0.05; black dots) and
CRHR1GABA−CKO (144.5 ± 9.5%; n = 7; p < 0.05; gray dots), but showed no
effect in CA1 hippocampal neurons of CRHR1Glu-CKO (98.2 ± 2.0%; n = 7;
p < 0.05; white dots). Insets show representative recording traces.
§ stimulation artifact. Black bar represents presence of CRH.
CRH (125 nM) increased PS amplitude to 197.3 ± 16.0% of
control (n = 3; p < 0.05; Figure 4C). Thus, an involvement of
CaV1.2 seems rather unlikely. However, when either the calcium
channel antagonists nifedipine or Ni2+ was added to the per-
fusate, the CRH-mediated enhancement in PS amplitude was
strongly impaired (132.3 ± 10.0% of control in the presence
of nif and 119.6 ± 5.9% of control in the presence of Ni2+;
Figure 4C). Hence, the CRH-mediated increase in PS ampli-
tude seems to be dependent on T- and L-type calcium channel
function. Interestingly, experiments from single-cell recordings
revealed, that CRH did neither affected currents through L-
type (96.8 ± 6.4% of control; n = 6; p > 0.05; Figure 4B) nor
through T-type (103.8 ± 16.4% of control; n = 7; p > 0.05;
Figure 4B) voltage gated calcium channels. Additionally, the
presence of the membrane-permeant calcium chelator BAPTA-
acetoxymethyl ester (30μM) did not diminish the CRH effect on
PS amplitude (data not shown).
Elevating NaV-activity enhances neuronal excitability (Clare
et al., 2000) and might contribute to the CRH-mediated effect.
The application of CRH did neither change the amplitude nor
the voltage-dependency of sodium currents (n = 8; Figure 5A).
CRH did not change AP amplitude (72.0 ± 3.2 vs. 65.9 ± 6.4mV;
data not shown) but slightly increased the AP frequency during
current injection of +130 pA (20.9 ± 1.0Hz control vs. 23.2 ±
0.6Hz CRH 125 nM; n = 8; p < 0.05; Figure 5B) and increased
the half-width of APs from 3.0 ± 0.0ms under control conditions
to 3.2 ± 0.0ms (Figure 5C). Plotting membrane potentials over
the corresponding current pulses demonstrates that CRH had no
effect on the I–V relationship (n = 6; Figure 5D).
The inhibition of potassium channels may also induce an
enhancement of neuronal excitability. In the presence of CRH
(125 nM) analysed charge values were reduced for IK (by 15.4 ±
4.6% and by 34.6 ± 7.3% when depolarized to 20 and 40mV,
respectively; n = 7; Figure 6D) and for IA currents (by 27.6 ±
6.0% and by 51.0 ± 19.2% at depolarization to 20 and 40mV,
respectively; n = 7, p < 0.05; Figure 6E). Depression of potas-
sium channels did not change resting membrane potential
(60.9 ± 2.0 vs. 58.8 ± 1.1mV; p > 0.05) of the recorded neurons.
DISCUSSION
Here we provide evidence that CRH increases neuronal excitabil-
ity of CA1 pyramidal neurons not by affecting synaptic transmis-
sion and mechanisms important for LTP, but by the modulation
of somatic voltage-gated ionic currents important for the gen-
eration of APs. We addressed the underlying mechanism by a
pharmacological approach and found an involvement of PP-2B
and the potassium currents IA and IK. Experiments in transgenic
animals revealed that the CRH-mediated effect depends solely on
activation of CRHR1 expressed on glutamatergic neurons.
The effect of CRH on neuronal excitability in the hippocam-
pus is still unclear. It has been described that CRH (125–250 nM)
increases neuronal excitability (Aldenhoff et al., 1983; Hollrigel
et al., 1998; Wang et al., 1998; Sillaber et al., 2002) and enhances
activity propagation through the hippocampal formation (von
Wolff et al., 2011). In contrast, the application of either lower or
higher CRH concentrations resulted in a depression of neuronal
activity (Rebaudo et al., 2001). In our experiments we exclu-
sively delivered a CRH concentration of 125 nM and observed
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FIGURE 3 | (A) The effect of CRH on CA1-LTP depends on the site of
electrical stimulation. When SC-stim-fEPSPs were recorded, CRH did not
change LTP induced by HFS (control: 173.3 ± 19.8 %; n = 5, in the
presence of CRH: 171.3 ± 8.2%; n = 5, p > 0.05). However, when HFS
was delivered to the CA3 stratum pyramidale, (B) CRH increased the
potentiation of CA3-stim-fEPSPs from 154.8 ± 5.0% (n = 6) under control
conditions to 180.6 ± 8.1% (n = 6; p < 0.05 for control vs. CRH). (C) The
effect of CRH on the population spike amplitude is dependent on
phosphatase 2B (PP-2B), voltage-gated potassium channels (KV) and T-
and L-type calcium channels. PS were recorded from the CA1 pyramidal
layer upon electrical stimulation of the Schaffer-collaterals. The inhibition
of PKA, PKC, and CaMKII with Kn252a (500 nM), H7 (100μM), and H89
(10μM), respectively did not affect the CRH-mediated effect on PS
amplitude. In the presence of the T- and L-type calcium channel
antagonist nifedipine (nif) and Ni2+, respectively, CRH failed to enhance
PS amplitudes (105.9 ± 7.6%; n = 6; p > 0.05). CRH did neither increase
PS amplitudes when PP-2B was inhibited with cycA (113.1 ± 7.3%; n = 6;
p > 0.05) nor when voltage-gated potassium channels were antagonized
with 4-aminopyridine (4-AP; 113.5 ± 6.2%; n = 6; p > 0.05). ∗∗p < 0.01;
∗∗∗p < 0.001.
enhanced neuronal excitability, in accordance with other studies
(Smith and Dudek, 1994; Hollrigel et al., 1998; Blank et al., 2002;
Eckart et al., 2002). The G-protein coupled CRHR1 is expressed
in the CA1 region (Dautzenberg and Hauger, 2002) and the
amount of total expression changes during development (Avishai-
Eliner et al., 1996). It has been shown that the effect of CRH on
PS amplitude in the hippocampal CA1 region is dependent on
CRHR1 activation (Sillaber et al., 2002), but it is still unclear,
whether it is mediated by CRHR1 expressed on glutamatergic or
GABAergic neurons. Even though, a recent study proved CRHR1
expression in the hippocampus only in glutamatergic neurons
and not in GABAergic interneurons (Refojo et al., 2011), there
is no functional evidence for the generation of PS support-
ing this on the monosynaptic level of CA3-CA1 synapses. Our
results from transgenic CRHR1Glu-CKO and CRHR1GABA-CKO
mice clearly demonstrate that the CRH-mediated increase in PS
amplitude is solely dependent on CRHR1 expressed on gluta-
matergic neurons.
CA1 stratum radiatum fEPSPs evoked by electrical stimulation
of Schaffer-collaterals reflect processes of synaptic transmission
that are below the threshold of AP generation in most of the target
cells (Andersen et al., 1966). Whereas CRH increased PS ampli-
tudes, fEPSPs were unaffected, making a direct CRH-dependent
modulation of synaptic transmission unlikely. Electrical stimu-
lation of the somatic region of CA3 pyramidal neurons ensures
the generation of APs at the axon hillock that propagate along
the Schaffer-collaterals finally resulting in transmitter release in
CA1 (Meeks andMennerick, 2007). Under these conditions, CRH
significantly increased fEPSP amplitudes in the CA1 region. In
contrast, when bypassing the AP generation site by a direct SC
Frontiers in Cellular Neuroscience www.frontiersin.org July 2013 | Volume 7 | Article 91 | 6
Kratzer et al. Neuronal actions of CRH
FIGURE 4 | CRH increases intracellular calcium influx in CA1 pyramidal
neurons upon electrical stimulation of the Schaffer-collaterals. (A) Cells
were loaded with the calcium sensitive dye oregon green-AM. After 1 h of
incubation, the SC were electrically stimulated every 15 s and calcium influx
was recorded simultaneously (sampling rate 20Hz; duration 1.5 s). In the
presence of CRH the intracellular Ca2+−influx during synaptic activity
increased to 231.7 ± 13.8% of control (n = 4; p < 0.05). Right insets:
Videomicroscopic photograph of the CA1 region of the hippocampus and
fluorescence recorded under control conditions (middle) and in the presence
of 125 nM CRH (lower inset). (B) Barium currents through T- and L-type
calcium channels were recorded in single-cell voltage-clamp recordings. CRH
did neither increase L-currents (96.8 ± 6.4% of control; n = 6; p > 0.05) nor
T-currents (103.8 ± 16.4% of control; n = 7; p > 0.05). (C) PS amplitudes
recorded from CaV1.2CNS-CKO animals were increased to 197.3 ± 16.0% of
control (n = 3; p < 0.05). The effect of CRH on PS amplitude in CNS-CKO
animals was diminished in the presence of the calcium channel antagonists
nifedipine (132.3 ± 10.0% of control; n = 4; p < 0.05) or Ni2+ (119.6 ± 5.9%
of control; n = 5; p < 0.05). ∗p < 0.05; ∗∗p < 0.01.
FIGURE 5 | CRH does not modulate NaV channels but increases spiking
frequency and prolongs action potentials. Sodium currents were elicited
by depolarizing the membrane from −70 to −20mV (U = 2mV). (A) The
normalized amplitude of Na+-channel current amplitudes was plotted against
the membrane potential. NaV channels showed half-maximum activation
(V1/2) of 57.4 ± 0.2mV (n = 7) under control conditions. In the presence of
CRH (125 nM) V1/2 was not significantly different (52.8 ± 0.3; n = 7;
p > 0.05). (B) Action potentials were elicited by inducing a depolarizing
current of +130 pA and had a mean frequency of 20.9 ± 1.0Hz. Application of
CRH resulted in a significant increase in the frequency (23.2 ± 0.6Hz; n = 8;
p < 0.05). (C) Compared to control, CRH prolonged the half-width of APs
from 3.0 ± 0.0 to 3.2 ± 0.0ms (n = 8; p < 0.05). (D) Current-voltage
relationships revealed that CRH does not change membrane resistance in
CA1 pyramidal neurons. ∗p < 0.05.
stimulation, somatic excitability does not determine fEPSP ampli-
tudes and CRH did not affect fEPSP. Equivalent results were
obtained, when testing how CRH influences CA1-LTP. LTP is
the major in vitro correlate for processes related to memory
generation (Bliss and Collingridge, 1993). Analogous to the
increase of the PS amplitude, LTP was enhanced by CRH only
whenHFSwas delivered to the CA3 pyramidal layer and remained
unchanged when SCs were stimulated.
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FIGURE 6 | CRH reduces currents through A-type (IA) and delayed
rectifier (IK) potassium channels. In the voltage clamp mode,
currents through voltage gated potassium channels were recorded
upon stepwise depolarization of CA1 pyramidal neurons from −50 to
+40mV (U = 10mV). (A) Representative recording traces under
control conditions (black traces) and in the presence of CRH 125 nM
(gray traces). (B) A preceding hyperpolarizing step (100ms)
de-inactivates fast IA and allows the graphical subtraction of currents
with and without the preceding hyperpolarizing step (C), IA currents
can be analyzed. (C) Representative recording traces of IA currents
under control conditions (black) and in the presence of CRH 125 nM
(gray). (D) After application of CRH, currents through delayed rectifier
potassium channels (IK) were reduced by 14.2 ± 5.7% to 30.4 ± 6.6%
dependent on the voltage step. (E) CRH significantly reduced IA
currents ranging from 30.1 ± 6.0% to 83.2 ± 26.8% depending on the
voltage step (n = 5; p < 0.05). ∗p < 0.05; ∗∗p < 0.01. Insets show
representative recording traces; leak subtraction was performed with
the P/4 subtraction protocol.
The CRH-mediated increase in neuronal excitability has been
shown to be dependent on PKA and PKC (Blank et al., 2003).
However, our results suggest a contribution of PP-2B in the CRH-
induced enhancement of PS amplitude. It has been shown, that,
dependent on the mouse strain, signal processing of CRH can be
mediated by different transduction pathways. Blank et al. (2003)
described that CRH activates PKA in C57/BL6 whereas in BALB/c
mice CRHR1 is coupled to the PKC pathway (Blank et al., 2003).
These data might explain the discrepancy to the present study,
since we used for our experiments slices from CD-1 mice. To
our knowledge this is the first report demonstrating an effect
of CRHR1 via neuronal PP-2B. Recently, it has been shown that
CRHR1 is coupled to the PP-2B-nuclear factor of activated T-cells
(NFAT) signaling pathway and its activation is a prerequisite for
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CRH-induced catecholamine production from chromaffin cells
(Dermitzaki et al., 2012). Other neuropeptides appear to affect
the PP-2B/NFAT pathway including substance P (Seybold et al.,
2006) and angiotensin (saygili et al., 2009).
In rat and mouse corticotrophs, CRH has been reported to
stimulate Ca2+ entry through VGCCs in a cAMP- and PKA-
dependent manner (Lee and Tse, 1997; Kovalovsky et al., 2002).
However, the CRH effect in our experiments was not depen-
dent on PKA. CRH is known to increase cellular cAMP levels
by an activation of adenylyl cyclase (Chen et al., 1986; Riegel
and Williams, 2008). A direct activation of PP-2B by elevated
intracellular cAMP has been reported in hepatocytes (Webster
et al., 2002) and PP-2B might therefore also be cAMP-sensitive
in hippocampal neurons.
In voltage-clamp experiments CRH did not affect charge
transfer or activation kinetics of sodium channel currents which
makes a direct modulation of sodium channels unlikely. Instead,
CRH increased the frequency and prolonged the decay time
of APs recorded from CA1 pyramidal neurons. These results
point to a modulation of ionic conductances attributed to mem-
brane repolarization. A comparable broadening of APs was
reported, when the potassium channel antagonist 4-AP was
applied to hippocampal CA3 neurons (Mitterdorfer and Bean,
2002). Potassium channels from the Kv1-family are generally
sensitive to 4-AP (Coetzee et al., 1999), are expressed in the
hippocampus (Grosse et al., 2000) and can produce IK or IA
depending on subunit composition (Clark et al., 2009).We clearly
show that CRH depresses IA and IK. Moreover, CRH failed to
increase PS amplitudes in the presence of 4-AP that blocks KV1
and KV3 at micromolar concentrations (Johnston et al., 2010) as
used in our study. These results strongly suggest that a modu-
lation of potassium channel currents, specifically IA and IK is a
key mechanism of the CRH-mediated enhancement of neuronal
excitability of CA1 pyramidal neurons.
Potassium channels of the KV1 subfamily are of particular
interest as a possible target for CRHR1-dependent signaling: KV1
are highly expressed at the axonal hillock and may influence spike
initiation (Clark et al., 2009). This is well in accordance with
our finding, that CRH increases neuronal excitability when trans-
mitter release is dependent on AP initiation at CA3 pyramidal
neurons and did not change synaptic activity when the site of
AP initiation was bypassed. The threshold for AP generation is
dynamically regulated by KV1 channels and inhibition increases
neuronal firing (Chi and Nicol, 2007). Kv1 channels can be inac-
tivated by PP-2B dephosphorylation (Roeper et al., 1997) so that a
CRH-induced activation of PP-2B might downregulate IK and IA.
In the presence of the L- and T-Type calcium channel antag-
onists nifedipine and Ni2+ CRH failed to increase PS amplitudes
suggesting an involvement of these VGCCs. Two L-type isoforms
are generally prevalent throughout the CNS: Cav1.2 and Cav1.3.
In the neocortex and hippocampus, the vast majority belong to
the Cav1.2 subtype (Lacinova et al., 2008). As we did not observe
a reduced effect of CRH on PS amplitude in CaV1.2 knockout ani-
mals, the action of CRH on PS amplitude seems to be dependent
on CaV1.3. Additionally, T-type channels seem to be involved as
application of Ni2+ strongly reduced the CRH-mediated effect.
However, in single cell recordings, CRH showed no impact on
currents through T- or L-type calcium channels. Furthermore,
blocking intracellular Ca2+ with BAPTA did not deteriorate the
CRH-mediated effect on PS amplitude. All together, these results
indicate that Ca2+ as a messenger is not crucial involved in the
CRH-dependent increase of neuronal activity. But still, an impor-
tant question remains: How are T- and L-type VGCCs involved
in the observed effects? One parsimonious explanation might be
that these channels contribute to the PS enlargement not by an
increased Ca2+ current through each single channel but by an
increment of the total number of channel activated since more
and more neurons being faster depolarized due to the threshold
lowering for AP generation triggered by CRH-dependent KV1
inhibition. According to this explanation, we observed elevated
Ca2+ influx in CA1 neurons upon afferent stimulation after CRH
application.
In summary, our data demonstrate that CRH does not affect
synaptic excitability per se, but increases PS amplitude in CA1
neurons. We provide evidence that signal processing of CRH in
the hippocampus of CD1 mouse strains was mediated through a
PP-2B dependent signal transduction, finally attenuating somatic
IK and IA. The somatic AP initiation site appears to be essential
for the CRHR1-mediated enhancement of neuronal excitability.
Hypersecretion of central CRH is thought to play an important
role in the pathophysiology of stress-related mental disorders,
such as major depressive disorder and PTSD. These findings may
represent an important step toward understanding the cellular
andmolecular processes underlying CRH-mediated physiological
and pathophysiological effects.
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